Fulgent Genetics Affirms FY2025 GAAP EPS Guidance of $(1.95) vs $(1.34) Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Fulgent Genetics (NASDAQ:FLGT) affirms FY2025 GAAP EPS guidance from $(1.95) to $(1.95) vs $(1.34) analyst estimate..
Fulgent Genetics (NASDAQ:FLGT) affirms FY2025 GAAP EPS guidance from $(1.95) to $(1.95) vs $(1.34) analyst estimate..